Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsVAGINALGeneric

GYNE-LOTRIMIN 3

CLOTRIMAZOLE

Standard Dose
200MG
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Discontinued
Summary

Approval overview GYNE-LOTRIMIN 3 is listed in Drugs@FDA under application 020525 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOTRIMAZOLE Form and strength TABLET;VAGINAL - 200MG Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2000-09-01 00:00:00.

Structured Monograph

Clinical summary

Approval overview GYNE-LOTRIMIN 3 is listed in Drugs@FDA under application 020525 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CLOTRIMAZOLE Form and strength TABLET;VAGINAL - 200MG Sponsor BAYER HEALTHCARE LLC Submission history Latest submission status date: 2000-09-01 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Discontinued
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.